Biography
Javier Del Pino received his PharmD degree at the University Complutense University of Madrid in 2004. He has two Masters in Sciences 2009 and 2010. He specialized in\r\nneurotoxicology and neurodevelopmental toxicology and received his PhD in Toxicology in 2009. In 2010 he worked in Institute of Health Carlos III in the National Center of\r\nEnvironmental Health. From 2010 to 2012, he was Associated Researcher at University of Massachusetts (UMASS) working in Sandra Petersen´s Lab in a National Institute\r\nof Health (NIH) project on developmental effects of TCDD endocrine disruptor on sexual differentiation. In 2012, he got a position as Assistant Professor of Toxicology at\r\nthe Complutense University of Madrid.
Abstract
4-Aminopyridine (4-AP) is an orphan drug indicated for the treatment of neuromuscular disorders. There is a great controversy\r\naround the use of this drug because of its narrow safety index and because a large number of adverse effects have been reported.\r\nMoreover, it was shown to induce cell death in different cell lines, being reported mainly apoptosis and necrosis as the principal\r\npathways of cell death mediated by blockage of K channels or the Na, K-ATPase, but until now it was not described in vivo cell death\r\ninduced by 4-aminipyridine. To provide new sub chronic toxicity data and specifically, evaluate if 4-AP (2, 4 and 10 mg/kg) is able\r\nto induce in vivo cell death process and the main pathways related to it, a repeated dose (28 days) oral toxicity study, at therapeutic\r\nrange of doses, was conducted in rats. The anatomical pathology, the biochemical and hematological parameters were analyzed. The\r\nleucocytes number, the lactate dehydrogenase (LDH) and aspartate aminotransferase (AST) enzymatic activity were increased at\r\nall dose but the erythrocytes number, the hemoglobin concentration, the alkaline phosphatase (FAL) and alanine aminotransferase\r\n(ALT) enzymatic activity were increased only at highest dose studied. However, glucose levels decreased at all doses. The biochemical\r\nresults are indicative of hepatic damage. The anatomy pathology studies showed cell death only on liver and kidney. The present work\r\nshows for the first time in vivo cell death on liver and kidney.
Biography
Narges Elgolli has completed her PhD from the University of Paris, VII Denis Diderot in France. She is currently an Assistant Professor Doctor at the Faculty of Sciences,\r\nTunis University, in the Laboratory of Aggression Physiology and Endocrine Metabolic Studies, in Tunisia.
Abstract
Nicotine, contained in classic cigarettes is known to to have a wide variety of deleterious effects. Electronic cigarettes, as a\r\nsubstitute to nicotine, are becoming increasingly popular, although there is no evidence regarding their safety. Considering\r\nthe dearth of information about e-cigarette toxicity, our study was designed to compare nicotine alone to e-liquid with or without\r\nnicotine on lung histopathology in Wistar rats. E-liquid associated or not associated to nicotine and nicotine alone (0.5 mg/kg of\r\nbody weight) were administered intra-peritoneally during 28 days. Histological studies were conducted and hematoxilin-eosin-safran\r\ncoloration test was performed While nicotine treated rats exhibited peri-arteriolar fibrosis, lymphocytes infiltration and arteriolar\r\nobstruction, more critical alterations were observed after the e-liquid without nicotine treatment: Peri-arteriolar and peri-bronchiolar\r\nfibrosis, lymphocytes infiltration, arteriolar obstruction and giant cells. Treatment with e-liquid associated to nicotine led to the same\r\nimportant histo-pathological changes but with additional granulomas. So, e-liquid, per se is able to induce lung toxicity. Furthermore,\r\ne-liquid promotes more damages than nicotine and the combination of the two leads to damages of even more seriousness. E-liquid\r\nmust be used with caution.